Heartware International Inc. ADR (HTWR)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Douglas Evan Godshall
Employees:
625
500 OLD CONNECTICUT PATH, FRAMINGHAM, MA 01701
508-739-0873

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

HeartWare International, Inc., a medical device company, designs, develops, manufactures, and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States, German...

Data derived from most recent annual or quarterly report
Market Cap 1.018 Billion Shares Outstanding17.55 Million Avg 30-day Volume 179.384 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.62
Price to Revenue3.9413 Debt to Equity1.1348 EBITDA-42.998 Million
Price to Book Value5.9844 Operating Margin-16.9887 Enterprise Value970.565 Million
Current Ratio5.288 EPS Growth-0.165 Quick Ratio4.432
1 Yr BETA 0.577 52-week High/Low 0.0 / Profit Margin-23.0285
Operating Cash Flow Growth-216.5133 Free Cash Flow to Firm (FCFF) TTM -28.113 Million Free Cash Flow to Equity (FCFE) TTM-32.944 Million
Altman Z-Score1.5964
View SEC Filings from HTWR instead.

View recent insider trading info

Funds Holding HTWR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HTWR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2016-08-26:
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
  • 8-K: filed on 2016-08-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
    Item 5.01: Changes in Control of Registrant
  • 8-K: filed on 2016-07-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-06-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-06-27:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-06-06:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-03-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-02-25:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-02-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LARKIN C RAYMOND JR

    • Director
    No longer subject to file 2016-08-23 0

    MCAREE PETER F SVP, CFO AND TREASURER

    • Officer
    No longer subject to file 2016-08-23 0

    BARBERICH TIMOTHY J

    • Director
    No longer subject to file 2016-08-23 0

    OESTERLE STEPHEN N

    • Director
    No longer subject to file 2016-08-23 0

    FELDMANN CYNTHIA L

    • Director
    No longer subject to file 2016-08-23 0

    GODSHALL DOUGLAS EVAN PRESIDENT & CHIEF EXEC OFFICER

    • Officer
    • Director
    No longer subject to file 2016-08-23 0

    LAROSE JEFFREY CHIEF SCIENTIFIC OFFICER

    • Officer
    No longer subject to file 2016-08-23 0

    THOMAS ROBERT BAIN

    • Director
    No longer subject to file 2016-08-23 0

    STOCKMAN ROBERT BERNARD

    • Director
    No longer subject to file 2016-08-23 0

    WADE DENIS NEWELL

    • Director
    No longer subject to file 2016-08-23 0

    HARRISON SETH LORING

    • Director
    No longer subject to file 2016-08-23 0

    SCHUERMANN JAMES SVP, SALES & MARKETING

    • Officer
    No longer subject to file 2016-08-23 0

    KNOPF LAWRENCE J GENERAL COUNSEL

    • Officer
    No longer subject to file 2016-08-23 0

    STRONG MARK SENIOR VP, R&D AND QUALITY

    • Officer
    No longer subject to file 2016-08-23 0

    LEADLEY KATRIN CHIEF MEDICAL OFFICER

    • Officer
    No longer subject to file 2016-08-23 0

    CORNELL CHADWICK

    • Director
    No longer subject to file 2016-08-23 0

    YOCHER ROBERT E SVP REGULATORY AFFAIRS

    • Officer
    23,505 2015-12-21 0

    ADAGE CAPITAL PARTNERS GP LLC

    ADAGE CAPITAL PARTNERS, L.P.

    ADAGE CAPITAL ADVISORS, L.L.C.

    ATCHINSON ROBERT

    GROSS PHILLIP

    • 10% Owner
    No longer subject to file 2015-07-31 0

    HATHAWAY DAVID R CHIEF MEDICAL OFFICER

    • Officer
    0 2014-03-10 0

    FARRELL LAUREN VP, FINANCE

    • Officer
    14,961 2012-12-20 0

    BENNETT CHRISTINE CONSTANCE

    • Director
    No longer subject to file 2012-05-31 0

    APPLE TREE PARTNERS I LP

    • FORMER 10% OWNER (NOW 7.64%)
    No longer subject to file 2012-03-01 0

    MCINTYRE DAVID CFO & COO

    • Officer
    No longer subject to file 2011-12-19 0

    PAZ RAMON VP, QUALITY ASSURANCE

    • Officer
    No longer subject to file 2011-09-16 0

    HELD JEFFREY GENERAL COUNSEL

    • Officer
    0 2010-12-20 0

    YOMTOV BARRY VP, ENGINEERING

    • Officer
    No longer subject to file 2010-03-02 0

    SATTER MUNEER A

    • 10% Owner
    1,085,718 2009-08-13 0

    FOLEY JENNIFER VICE PRES., CLIN & REG AFFAIRS

    • Officer
    20,000 2008-06-05 0

    REEDY JANE VICE PRESIDENT, CLINICAL & MKT

    • Officer
    0 2007-06-28 0

    ROWE DOZIER CHIEF OPERATING OFFICER

    • Officer
    10,000 2007-06-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments